Hardy Diagnostics releases a rapid test for the coronavirus
Hardy Diagnostics has announced the release of a rapid test for patients suspected of COVID-19 infection
Hardy Diagnostics has announced the release of a rapid test for patients suspected of COVID-19 infection
The Sentosa® SQ HIV-1 Genotyping Assay is the first FDA De Novo-designated NGS assay for detecting HIV-1 drug resistance mutations
Watch this webinar to find out how to accelerate your workflow using high-throughput flow cytometry
Latest edition includes two new chapters for scientists who perform cell biology assays
SelectScience is heading to Chicago, USA, to interview scientists at the forefront of neuroscience research and report on the latest techniques and technologies advancing the field
Tell us which new products made the most difference to your lab work and you’ll have the chance to win one of four $500 Amazon gift cards
Following last year’s success, we’re hosting our second annual event dedicated to celebrating our Seals of Quality program
In this expert on-demand webinar, learn about the most common barriers to successful assay optimization and the importance of monitoring workflows
The UK trade show dedicated to the laboratory industry has launched free advance registration for visitors
Learn how the use of covalent compounds within the pharmaceutical industry can improve drug discovery
The new division, led by Dr. Phil Jones, aims to offer a comprehensive drug discovery service to customers
Gyrolab Generic TK Kit for early-stage biotherapeutic development
Program is 'invaluable' for scientists needing to make informed purchasing decisions for their lab
Discover how a research group at the University of Geneva, Switzerland, is using an innovative approach to accelerate therapeutics through the drug development process
SelectScience is excited to be attending AACR 2017, Washington D.C., USA
Bruker Daltonics and AstraZeneca among those recognized during prestigious ceremony at SLAS2017
Diverse chemical libraries: allowing for the interrogation of a wide range of targets and pathways when prior information is not available.